GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Centessa Pharmaceuticals PLC (STU:260) » Definitions » EV-to-EBIT

Centessa Pharmaceuticals (STU:260) EV-to-EBIT : -5.15 (As of May. 24, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Centessa Pharmaceuticals EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Centessa Pharmaceuticals's Enterprise Value is €731.40 Mil. Centessa Pharmaceuticals's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was €-142.00 Mil. Therefore, Centessa Pharmaceuticals's EV-to-EBIT for today is -5.15.

The historical rank and industry rank for Centessa Pharmaceuticals's EV-to-EBIT or its related term are showing as below:

STU:260' s EV-to-EBIT Range Over the Past 10 Years
Min: -6.42   Med: -5.22   Max: -2.93
Current: -5.21

During the past 5 years, the highest EV-to-EBIT of Centessa Pharmaceuticals was -2.93. The lowest was -6.42. And the median was -5.22.

STU:260's EV-to-EBIT is ranked worse than
100% of 421 companies
in the Biotechnology industry
Industry Median: 10.43 vs STU:260: -5.21

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Centessa Pharmaceuticals's Enterprise Value for the quarter that ended in Mar. 2024 was €872.24 Mil. Centessa Pharmaceuticals's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was €-142.00 Mil. Centessa Pharmaceuticals's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was -16.28%.


Centessa Pharmaceuticals EV-to-EBIT Historical Data

The historical data trend for Centessa Pharmaceuticals's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Centessa Pharmaceuticals EV-to-EBIT Chart

Centessa Pharmaceuticals Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
- - - 0.14 -3.70

Centessa Pharmaceuticals Quarterly Data
Dec19 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.50 -1.96 -2.48 -3.70 -6.45

Competitive Comparison of Centessa Pharmaceuticals's EV-to-EBIT

For the Biotechnology subindustry, Centessa Pharmaceuticals's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Centessa Pharmaceuticals's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Centessa Pharmaceuticals's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Centessa Pharmaceuticals's EV-to-EBIT falls into.



Centessa Pharmaceuticals EV-to-EBIT Calculation

Centessa Pharmaceuticals's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=731.396/-141.995
=-5.15

Centessa Pharmaceuticals's current Enterprise Value is €731.40 Mil.
Centessa Pharmaceuticals's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-142.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Centessa Pharmaceuticals  (STU:260) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Centessa Pharmaceuticals's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2024 ) =EBIT / Enterprise Value (Q: Mar. 2024 )
=-141.995/872.243
=-16.28 %

Centessa Pharmaceuticals's Enterprise Value for the quarter that ended in Mar. 2024 was €872.24 Mil.
Centessa Pharmaceuticals's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-142.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Centessa Pharmaceuticals EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Centessa Pharmaceuticals's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Centessa Pharmaceuticals (STU:260) Business Description

Traded in Other Exchanges
Address
1 Ashley Road, 3rd Floor, Altrincham, Cheshire, GBR, WA14 2DT
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include 1) SerpinPC for Hemophilia A, B, 2) LB101 for Solid Tumors, 3) ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders, 4) MGX292 Pulmonary Arterial Hypertension (PAH) and 5) Undisclosed for Solid Tumors.

Centessa Pharmaceuticals (STU:260) Headlines

No Headlines